0001181431-13-064117.txt : 20131220
0001181431-13-064117.hdr.sgml : 20131220
20131220165603
ACCESSION NUMBER: 0001181431-13-064117
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20131218
FILED AS OF DATE: 20131220
DATE AS OF CHANGE: 20131220
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ACHILLION PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001070336
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 300 GEORGE STREET
CITY: NEW HAVEN
STATE: CT
ZIP: 06511
BUSINESS PHONE: 203-624-7000
MAIL ADDRESS:
STREET 1: 300 GEORGE STREET
CITY: NEW HAVEN
STATE: CT
ZIP: 06511
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: QVT Associates GP LLC
CENTRAL INDEX KEY: 0001290166
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33095
FILM NUMBER: 131292151
BUSINESS ADDRESS:
STREET 1: 1177 AVENUE OF THE AMERICAS
STREET 2: 9TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10036
BUSINESS PHONE: 212-705-8800
MAIL ADDRESS:
STREET 1: 1177 AVENUE OF THE AMERICAS
STREET 2: 9TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10036
4
1
rrd398189.xml
FORM 4
X0306
4
2013-12-18
0
0001070336
ACHILLION PHARMACEUTICALS INC
ACHN
0001290166
QVT Associates GP LLC
1177 AVENUE OF THE AMERICAS
9TH FLOOR
NEW YORK
NY
10036
0
0
1
0
Common Stock, $0.001 par value
2013-12-18
4
S
0
89812
3.06
D
11530338
I
Through QVT Fund IV LP, QVT Fund V LP and Quintessence Fund L.P.
Common Stock, $0.001 par value
2013-12-19
4
S
0
100000
3.09
D
11430338
I
Through QVT Fund IV LP, QVT Fund V LP and Quintessence Fund L.P.
Common Stock, $0.001 par value
2013-12-19
4
S
0
32800
3.15
D
11397538
I
Through QVT Fund IV LP, QVT Fund V LP and Quintessence Fund L.P.
On December 18, 2013, QVT Fund IV LP sold 11,535 shares of Common Stock, Quintessence Fund L.P. sold 9,950 shares of Common Stock and QVT Fund V LP sold 68,327 shares of Common Stock. On December 19, 2013, QVT Fund IV LP sold 17,055 shares of Common Stock, Quintessence Fund L.P. sold 14,713 shares of Common Stock and QVT Fund V LP sold 101,032 shares of Common Stock. As a result, QVT Fund IV LP directly beneficially owns 1,463,894 shares of Common Stock, Quintessence Fund L.P. directly beneficially owns 1,262,772 shares of Common Stock and QVT Fund V LP directly beneficially owns 8,670,872 shares of Common Stock. QVT Associates GP LLC is the general partner of QVT Fund IV LP, QVT Fund V LP and Quintessence Fund L.P. (together with QVT Fund IV LP, and QVT Fund V LP, the "Funds"). QVT Financial LP is the investment manager for the Funds and therefore may be deemed the beneficial owner of the Common Stock held by the Funds. QVT Financial GP LLC is the general partner of QVT Financial LP and therefore may be deemed the beneficial owner of Common Stock beneficially owned by QVT Financial LP. The reporting person disclaims beneficial ownership of the reported securities except to the extent of its pecuniary interest therein.
/s/ Tracy Fu, Managing Member
2013-12-20